Form 4: OptiNose Director Heyman Tomas J. Acquires 75,000 Stock Options
SEC Form 4 Filing
Director Heyman Tomas J. acquired 75,000 stock options in OptiNose, Inc. on June 6, 2024, according to a Form 4 filing.
Summary
- On June 6, 2024, Tomas J. Heyman, a director of OptiNose, Inc., acquired 75,000 stock options with an exercise price of $1.04.
- The options vest on the earlier of June 6, 2025, or the Issuer's 2025 annual meeting of stockholders, contingent upon continued service with the Issuer.
- Following the transaction, Heyman directly owns 75,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard insider transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Future Outlook
The vesting of the options is contingent upon continued service with the Issuer, suggesting an expectation of continued involvement by the director.
Industry Context
Form 4 filings are standard disclosures for insiders, providing transparency into their transactions and holdings in the company. This is a routine part of corporate governance.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of transaction: Tomas J. Heyman acquired 75,000 stock options. |
| 06/06/2025 | Earliest vesting date for the stock options, contingent upon continued service. |
| 06/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.